Joseph Goldstein
Clinical Genetics (M.D.) · Dallas, TXNPI 1639640576
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (57.5%), ownership interests and travel and lodging — rather than concentrated in one kind of arrangement. Every reported general payment came from a single manufacturer, Regeneron. Among clinical genetics (m.d.) clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 305 payments — averaging $18,078 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron$5.5M
What the payments were for
- Consulting fees$3,169,75557%
- Travel & lodging$531,75910%
- Food & beverage$12,2340%
- Gifts$140%
- Ownership interest$1,800,08733%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron | 305 | $5,513,849 |
How this compares
$5,513,849 in reported general payments places this provider in the 95th percentile of 37 clinical genetics (m.d.) providers in Texas.
Other clinical genetics (m.d.) in Dallas
- Markey McNuttDallas$247K
- Steven BloomDallas$55
- Joseph RayGalveston$642K
- Hope NorthrupHouston$180K
- Paul HillmanHouston$68K
- Erin CooneyLeague City$44K
- Brendan LeeHouston$28K
- David RodriguezHouston$28K
- Fernando ScagliaHouston$16K
- Candace GambleFort Worth$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.